541 related articles for article (PubMed ID: 16614742)
21. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption.
Marcellin P; Pequignot F; Delarocque-Astagneau E; Zarski JP; Ganne N; Hillon P; Antona D; Bovet M; Mechain M; Asselah T; Desenclos JC; Jougla E
J Hepatol; 2008 Feb; 48(2):200-7. PubMed ID: 18086507
[TBL] [Abstract][Full Text] [Related]
22. Patterns of progression: unpredictability and risk of decompensated cirrhosis.
Tassopoulos NC
Dig Dis Sci; 1996 Dec; 41(12 Suppl):41S-48S. PubMed ID: 9011475
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
24. Risk factors and prevention of hepatocellular carcinoma in HCV infection.
Benvegnù L; Alberti A
Dig Dis Sci; 1996 Dec; 41(12 Suppl):49S-55S. PubMed ID: 9011476
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C Virus Infection in HIV-infected Patients.
Sulkowski MS
Curr Infect Dis Rep; 2001 Oct; 3(5):469-476. PubMed ID: 11559468
[TBL] [Abstract][Full Text] [Related]
26. Association of interferon lambda-4 rs12979860 polymorphism with hepatocellular carcinoma in patients with chronic hepatitis C infection.
de Bitencorte JT; Rech TF; Lunge VR; Dos Santos DC; Álvares-da-Silva MR; Simon D
World J Hepatol; 2021 Jan; 13(1):109-119. PubMed ID: 33584990
[TBL] [Abstract][Full Text] [Related]
27. T-cell therapy for chronic viral hepatitis.
Bertoletti A; Tan AT; Koh S
Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
[TBL] [Abstract][Full Text] [Related]
28. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
29. China's efforts to shed its title of "Leader in liver disease".
Li X; Xu WF
Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
[TBL] [Abstract][Full Text] [Related]
30. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.
Poynard T; Bedossa P; Opolon P
Lancet; 1997 Mar; 349(9055):825-32. PubMed ID: 9121257
[TBL] [Abstract][Full Text] [Related]
31. Hepatocellular carcinoma and hepatitis C in the United States.
El-Serag HB
Hepatology; 2002 Nov; 36(5 Suppl 1):S74-83. PubMed ID: 12407579
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.
Kramer JR; El-Serag HB; Taylor TJ; White DL; Asch SM; Frayne SM; Cao Y; Smith DL; Kanwal F
J Viral Hepat; 2017 Nov; 24(11):955-965. PubMed ID: 28815822
[TBL] [Abstract][Full Text] [Related]
33. Liver fibrosis progression in hepatitis C virus infection after seroconversion.
Butt AA; Yan P; Lo Re V; Rimland D; Goetz MB; Leaf D; Freiberg MS; Klein MB; Justice AC; Sherman KE;
JAMA Intern Med; 2015 Feb; 175(2):178-85. PubMed ID: 25485735
[TBL] [Abstract][Full Text] [Related]
34. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C.
García-Samaniego J; Rodríguez M; Berenguer J; Rodríguez-Rosado R; Carbó J; Asensi V; Soriano V
Am J Gastroenterol; 2001 Jan; 96(1):179-83. PubMed ID: 11197250
[TBL] [Abstract][Full Text] [Related]
35. Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
Fattovich G; Stroffolini T; Zagni I; Donato F
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S35-50. PubMed ID: 15508101
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus.
Sulkowski MS; Mast EE; Seeff LB; Thomas DL
Clin Infect Dis; 2000 Apr; 30 Suppl 1():S77-84. PubMed ID: 10770916
[TBL] [Abstract][Full Text] [Related]
37. Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis.
García-García JA; Romero-Gómez M; Girón-González JA; Rivera-Irigoin R; Torre-Cisneros J; Montero JL; González-Serrano M; Andrade RJ; Aguilar-Guisado M; Grilo I; Martín-Vivaldi J; Salmerón J; Caballero-Granado FJ; Macías J; Vergara-López S; Pineda JA; ;
AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1236-41. PubMed ID: 17209765
[TBL] [Abstract][Full Text] [Related]
38. Extrahepatic comorbidities associated with hepatitis C virus in HIV-infected patients.
Soriano V; Berenguer J
Curr Opin HIV AIDS; 2015 Sep; 10(5):309-15. PubMed ID: 26132342
[TBL] [Abstract][Full Text] [Related]
39. The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma.
Wirth TC; Manns MP
Ann Oncol; 2016 Aug; 27(8):1467-74. PubMed ID: 27226385
[TBL] [Abstract][Full Text] [Related]
40. [Monitoring patients with chronic hepatitis during and after therapy].
Colić-Cvrlje V; Mise S
Acta Med Croatica; 2009 Dec; 63(5):377-83. PubMed ID: 20198895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
